U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2005
130
Substance Class Protein
Created
by admin
on Wed Apr 02 08:44:31 GMT 2025
Edited
by admin
on Wed Apr 02 08:44:31 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
743QUY4VD8
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
HYALURONIDASE RECOMBINANT HUMAN
ORANGE BOOK  
FDA  
Preferred Name English
HYALURONIDASE (HUMAN RECOMBINANT)
USAN  
USAN  
Official Name English
LISPRO-PH20 COMPONENT RHUPH20
Common Name English
LISPRO-PH20 COMPONENT RECOMBINANT HUMAN HYALURONIDASE
Common Name English
vorhyaluronidase alfa [INN]
Common Name English
ENHANZE
Common Name English
HYALURONIDASE (HUMAN RECOMBINANT) [USAN]
Common Name English
HYALURONIDASE 1 (HUMAN SPERM SURFACE PROTEIN PH-20)-(1-447)PEPTIDE RECOMBINANT
Common Name English
CUMULASE
Brand Name English
HYQVIA COMPONENT HYALURONIDASE RECOMBINANT HUMAN
Brand Name English
HUMAN HYALURONIDASE
Common Name English
HYALURONIDASE HUMAN RECOMBINANT [MART.]
Common Name English
HYLENEX RECOMBINANT
Brand Name English
36-482-HYALURONOGLUCOSAMINIDASE PH20 (HUMAN) RECOMBINANT
Common Name English
HYALURONIDASE, HUMAN RECOMBINANT
Common Name English
HYALURONIDASE (HUMAN)
Common Name English
VORHYALURONIDASE ALFA [JAN]
Common Name English
HYALURONIDASE HUMAN RECOMBINANT
MART.  
Common Name English
VORHYALURONIDASE ALFA
INN   WHO-DD  
INN  
Official Name English
Vorhyaluronidase alfa [WHO-DD]
Common Name English
RHUPH20
Code English
HYALURONIDASE RECOMBINANT HUMAN [ORANGE BOOK]
Common Name English
HYALURONIDASE, HUMAN
Common Name English
RITUXAN HYCELA COMPONENT HYALURONIDASE (HUMAN RECOMBINANT)
Brand Name English
RHUPH-20
Code English
CHEMOPHASE
Brand Name English
SHP-671 COMPONENT RECOMBINANT HUMAN HYALURONIDASE
Common Name English
HYLENEX
Brand Name English
Classification Tree Code System Code
NDF-RT N0000175531
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
FDA ORPHAN DRUG 545616
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
FDA ORPHAN DRUG 529816
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
NDF-RT N0000007895
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
FDA ORPHAN DRUG 825421
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
FDA ORPHAN DRUG 514315
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
Code System Code Type Description
CAS
757971-58-7
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
USAN
RR-80
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
RXCUI
2119708
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
ALTERNATIVE
RXCUI
1300478
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
NCI_THESAURUS
C61504
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
INN
9907
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
EVMPD
SUB33117
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
SMS_ID
100000126356
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
DRUG BANK
DB06205
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201718
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
DAILYMED
743QUY4VD8
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
FDA UNII
743QUY4VD8
Created by admin on Wed Apr 02 08:44:31 GMT 2025 , Edited by admin on Wed Apr 02 08:44:31 GMT 2025
PRIMARY
From To
1_25 1_316
1_189 1_203
1_341 1_352
1_346 1_400
1_402 1_408
1_423 1_429
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_47
N 1_131
N 1_200
N 1_219
N 1_333
N 1_358
O 1_440
Related Record Type Details
Hyaluronidase-TQJC
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-ZZXF
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-OYSK
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-OCSQ
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-FIHJ
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-NVHY
SUB_CONCEPT->SUBSTANCE
Hyaluronidase-QVFC
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
HYALURONIDASE (HUMAN RECOMBINANT)
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:APPROXIMATE CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966